WEST PHARMACEUTICAL SERVICES, INC. Oci Equity Method Investment Tax Parent
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Oci Equity Method Investment Tax Parent of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:OciEquityMethodInvestmentTaxParent · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for the quarter ending 2026-06-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for the quarter ending 2026-03-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for the quarter ending 2025-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for the quarter ending 2025-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for fiscal 2025 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for fiscal 2024 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for fiscal 2023 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. oci equity method investment tax parent for fiscal 2022 was $0.00.
| Period end | Oci Equity Method Investment Tax Parent 3 month | Oci Equity Method Investment Tax Parent 6 month | Oci Equity Method Investment Tax Parent 9 month | Oci Equity Method Investment Tax Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-23 | $0.00 10-Q · filed 2026-07-23 | $0.00 derived: sum of 3 quarters · filed 2026-07-23 | $0.00 derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-23 | $0.00 derived: sum of 2 quarters · filed 2026-04-23 | $0.00 derived: sum of 3 quarters · filed 2026-04-23 | $0.00 derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-07-23 | $0.00 10-K · filed 2026-02-17 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-23 | $0.00 derived: sum of 2 quarters · filed 2026-07-23 | $0.00 10-Q · filed 2025-10-23 | $0.00 derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $0.00 10-Q · filed 2026-07-23 | $0.00 10-Q · filed 2026-07-23 | $0.00 derived: sum of 3 quarters · filed 2026-07-23 | $0.00 derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-23 | $0.00 derived: sum of 2 quarters · filed 2026-04-23 | $0.00 derived: sum of 3 quarters · filed 2026-04-23 | $0.00 derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-23 | $0.00 derived: sum of 2 quarters · filed 2025-10-23 | $0.00 10-Q · filed 2025-10-23 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-24 | $0.00 10-Q · filed 2025-07-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $0.00 10-Q · filed 2025-04-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-24 | $0.00 derived: sum of 2 quarters · filed 2024-10-24 | $0.00 10-Q · filed 2024-10-24 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-25 | $0.00 10-Q · filed 2024-07-25 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |